IMU 9.26% 5.9¢ imugene limited

Ann: Imugene First Patient Dosed in PD1-VAXX Clinical Trial, page-58

  1. 2,103 Posts.
    lightbulb Created with Sketch. 2335
    Hey oxxa,

    Here's the announcement put out on 6 August 2020 announcing that Imugene had received guidance from the US Food and Drug Administration in relation to the "development pathway" for VAXinia (CF33).

    Leslie has intimated that FDA IND approval should be received by the end of the year.

    http://www.aspecthuntley.com.au/docserver/02263638.pdf?fileid=02263638&datedir=20200806&edt=MjAyMC0xMi0wMSsxMjo0MjozNSs0ODArMTA3ODkzK2FuZHJld3dlc3QrcmVkaXJlY3QraHR0cDovL3d3dy5hc3BlY3RodW50bGV5LmNvbS5hdS9pbWFnZXNpZ25hbC9lcnJvcnBhZ2VzL3BkZnRpbWVvdXQuaHRtbCtodHRwOi8vd3d3LmFzcGVjdGh1bnRsZXkuY29tLmF1L2ltYWdlc2lnbmFsL2Vycm9ycGFnZXMvcGRmZGVsYXllZC5qc3A=
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.9¢
Change
0.005(9.26%)
Mkt cap ! $433.6M
Open High Low Value Volume
5.5¢ 5.9¢ 5.4¢ $1.489M 25.99M

Buyers (Bids)

No. Vol. Price($)
2 35252 5.9¢
 

Sellers (Offers)

Price($) Vol. No.
6.0¢ 1753430 24
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.